VIMPAT (lacosamide) is a prescription medication that belongs to a class of drugs known as antiepileptic or anticonvulsant medications. It is specifically designed to treat partial-onset seizures in adults and children who are at least 4 years old, and it can be used alone or in combination with other medications for epilepsy. VIMPAT works by stabilizing electrical activity in the brain, thereby reducing the frequency of seizures. It is available in several forms, including tablets, an injectable solution, and a syrup, allowing for flexibility in administration based on patient needs and preferences. Like all medications, VIMPAT can cause side effects, and its use should be closely monitored by a healthcare provider to ensure its safety and effectiveness for the individual patient.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.